Health

  • June 10, 2026

    Molina Says Its Warnings Doom Suit Over Guidance Cuts

    Health insurance provider Molina Healthcare and two of its executives urged a California federal court to dismiss a shareholder suit accusing them of misleading investors about medical costs and internal controls before repeatedly slashing the company's 2025 earnings guidance, arguing that the nature of its business makes costs unpredictable.

  • June 10, 2026

    AmeriHealth Unit, PBM Look To Escape Pharmacy Fee Suit

    The AmeriHealth Caritas Health Plan and its in-house pharmacy benefits manager asked a federal court to toss a proposed class action over "transmission fees," alleging the law that required disclosure of those fees, Pennsylvania's Human Services Code, doesn't let private parties sue.

  • June 10, 2026

    DC Circ. Asked To Freeze DOJ's Medical Pot Rescheduling

    A trade association for drug-testing companies and a biopharma firm developing marijuana-derived drugs have urged the D.C. Circuit to hit pause on a U.S. Department of Justice rule rescheduling state-sanctioned medical pot while their challenge to the policy change plays out.

  • June 10, 2026

    NJ Hospital Says Ex-CEO's Inaction At Event Supported Firing

    A New Jersey hospital urged a Garden State federal court to reject a bid from its former CEO for a finding that the hospital breached his employment agreement when it fired him over a topless art exhibit at a fundraising event, arguing that the ex-CEO has misinterpreted its sexual harassment policy.

  • June 10, 2026

    Goodwin, Covington Lead Parabilis' $670M Upsized IPO

    Venture-backed biotechnology firm Parabilis Medicines hit the public markets Wednesday after raising $670 million in its upsized initial public offering.

  • June 10, 2026

    Insurance Cos. Score Dismissal Of Zepbound Coverage Case

    A D.C. federal judge Wednesday agreed to toss a proposed class action against CVS Caremark and CareFirst BlueCross BlueShield from a worker who challenged coverage denials for Zepbound to treat sleep apnea, holding an exclusion in his employee health plan that the companies administered complied with federal benefits law.

  • June 10, 2026

    Lab To Pay $4.9M To Settle AGs' COVID Test Pricing Suit

    Eighteen states' attorneys general have entered into a $4.87 million settlement with GS Labs to resolve claims that the defunct testing company overcharged consumers for COVID-19 tests, according to statements issued Wednesday.

  • June 10, 2026

    NY Judge Says Insurer Owes No Coverage In $1.6M Care Row

    A New York federal judge said an insurer does not have to defend or indemnify a nursing and rehabilitation facility in a hospital's lawsuit seeking to recover $1.6 million in medical expenses for a former worker, finding Tuesday that the underlying action isn't a covered claim.

  • June 10, 2026

    Manatt Healthcare Pro Jumps To Crowell & Moring In LA

    A Manatt Phelps & Phillips LLP healthcare regulatory partner has joined Crowell & Moring LLP's Los Angeles office, the firm announced Wednesday.

  • June 10, 2026

    Conn. Woman Says Pharmacy 'Grossly' Exceeded Med Dose

    A New York compounding pharmacy injured a Connecticut woman by providing her with a medication that contained a "grossly excessive" amount of the active ingredient, as much as 91,511% of the dose on the label, according to a product liability and malpractice lawsuit.

  • June 10, 2026

    Houston Hospital System Settles Retirement Fee, Fund Fight

    A Texas hospital system agreed to settle a proposed class action from ex-workers alleging the healthcare nonprofit failed to curb excessive recordkeeping fees and remove underperforming funds from its $2.8 billion employee retirement plan, after a magistrate judge recommended denying its motion to dismiss an amended complaint in May.

  • June 10, 2026

    User Says 'Nature's Ozempic' Can't Keep Weight Loss Promise

    A proposed class of supplement buyers is suing the makers of Metabolism Ignite in California federal court, saying the supplements, advertised as "Nature's Ozempic," can't match the effectiveness of the name-brand medication that the advertisers compare it to.

  • June 10, 2026

    Colo. Sober Home Co. Says City Can't Escape Zoning Suit

    A Colorado sober living home operator has urged a federal court to reject a city's bid to dismiss its lawsuit, arguing that the city's zoning code unlawfully singles out people in recovery from addiction for land use approval requirements that other residents are not subjected to.

  • June 09, 2026

    Novartis, AbbVie Lose Bid To Halt Wash. 340B Pharmacy Law

    A Washington federal judge declined Tuesday to block a state law passed to protect prescription drug access for low-income and uninsured patients, rejecting arguments from AbbVie and Novartis that the new measure illegally adds to pharmaceutical manufacturers' obligations under the federal 340B Drug Pricing Program.

  • June 09, 2026

    Morrison Foerster Brings On Sidley Patent Litigation Duo

    A pair of Sidley Austin LLP patent and trade secrets litigators, including the firm's co-leader of its global intellectual property practice, have departed for Morrison Foerster LLP, according to an announcement made Tuesday.

  • June 09, 2026

    5 Firms Barred From Handling NFL Parkinson's Claims

    Five law firms have been disqualified from representing claimants seeking NFL concussion settlement funds for running a scheme that "laundered" questionable Parkinson's disease claims through the system to obtain $95 million, including $20 million in fees, a special masters' report issued Monday says.

  • June 09, 2026

    Calif. Judge Blocks DOJ's Bid For Trans Patients' Medical Info

    A California federal judge ordered Stanford Medicine hospital not to disclose medical information belonging to trans adolescents who received gender-related care in response to a Texas grand jury subpoena, and blocked the U.S. Department of Justice from taking further steps to obtain their patient records.

  • June 09, 2026

    Colo. Panel Unsure Surgeon Solely Liable For $67M Judgment

    A Colorado Court of Appeals panel pushed back Tuesday on oral arguments from counsel for a healthcare company arguing a surgeon was exclusively liable for the $67 million judgment entered in an underlying medical malpractice suit under the "captain of the ship" doctrine.

  • June 09, 2026

    Hospital Rating Group Calls $10.5M Fee Bid 'Unreasonable'

    The Leapfrog Group said Tenet Healthcare Corp.'s community hospitals "gratuitously overstaffed" their deceptive trade practices case against the hospital ratings nonprofit and urged a Florida federal court to deny or "massively reduce" Tenet's $10.5 million request for fees.

  • June 09, 2026

    Eli Lilly Wins Order Halting Alleged Trulicity Fraud

    A Florida federal judge signed off Tuesday on a preliminary injunction pausing a prescription cost share program purportedly for Church of God in Christ members that pharmaceutical giant Eli Lilly and Co. says is actually a fraud scheme to resell GLP-1 drug Trulicity on the secondary market.

  • June 09, 2026

    McKesson, Rite Aid Trust Clash Over Ch. 11 Claims Transfer

    McKesson locked horns Tuesday in New Jersey bankruptcy court with a trust created by Rite Aid's first Chapter 11 plan over whether the medication supplier must hand over antitrust claims against pharmaceutical companies.

  • June 09, 2026

    DOI About-Face Stokes Yearslong Cherokee Land Rights Fight

    The United Keetoowah Band of Cherokee Indians has for years been tied up in litigation with its sister tribe, the Cherokee Nation, over land rights, healthcare and more. Now, a recently withdrawn U.S. Department of the Interior memo over rights to 2.63 acres of land is again stoking tensions.

  • June 09, 2026

    ICE Contractor Challenges Colo. Health Inspection Law

    A federal contractor that runs an immigration detention center near Denver has sued to block enforcement of a new Colorado law requiring health and safety inspections at the facility, alleging the legislation is preempted by federal law.

  • June 09, 2026

    Pa. Law Firm Calls Uber and FedEx's RICO Suit A 'Sham'

    Nearly a month after its motion to dismiss a RICO suit filed by Uber and FedEx was denied by a Philadelphia federal judge, personal injury firm Simon & Simon PC has lodged a counterclaim against the companies, saying their complaint is a "frivolous sham."

  • June 09, 2026

    Health Tech Exec Defends $430K Wage Suit

    A former healthcare data platform chief strategy officer urged a North Carolina federal court to keep his $430,000 wage and commissions suit intact, arguing he has alleged enough ties to keep the case in the state and enough facts to let his claims move forward.

Expert Analysis

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

  • What FDA Guidance Means For Future Of Health Software

    Author Photo

    Two significant final guidance documents released by the U.S. Food and Drug Administration last month reflect a targeted effort to ease innovation friction around specific areas, including singular clinical decision support recommendations and sensor-based wearables, while maintaining established regulatory boundaries, say attorneys at Covington.

  • Opinion

    Federal Preemption In AI And Robotics Is Essential

    Author Photo

    Federal preemption offers a unified front at a decisive moment that is essential for safeguarding America's economic edge in artificial intelligence and robotics against global rivals, harnessing trillions of dollars in potential, securing high-skilled jobs through human augmentation, and defending technological sovereignty, says Steven Weisburd at Shook Hardy.

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

  • How State FCA Activity May Affect Civil Fraud Enforcement

    Author Photo

    A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.

  • Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

    Author Photo

    Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Assessing Compliance Risks Around TrumpRx Participation

    Author Photo

    As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.

  • California's New Privacy Laws Demand Preparation From Cos.

    Author Photo

    An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Predicting Actual Impact From CDC's New Vaccine Guidance

    Author Photo

    Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.

  • AI Scientific Discovery Order Implications For Life Sciences

    Author Photo

    President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.

  • What Rescheduling Means For Cannabis Labels, Marketing

    Author Photo

    The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.

  • What's At Stake In Possible Circuit Split On Medicaid Rule

    Author Photo

    A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.